Literature DB >> 10386612

Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens.

A J Simpson1, A I Maxwell, J R Govan, C Haslett, J M Sallenave.   

Abstract

Elafin (elastase-specific inhibitor) is a low molecular weight inhibitor of neutrophil elastase which is secreted in the lung. Using synthetic peptides corresponding to full-length elafin (H2N-1AVT.....95Q-OH), the NH2-terminal domain (H2N-1AVT.....50K-OH) and the COOH-terminal domain (H2N-51PGS.....95Q-OH), we demonstrate that elafin's anti-elastase activity resides exclusively in the COOH-terminus. Several characteristics of elafin suggest potential anti-microbial activity. The anti-microbial activity of elafin, and of its two structural domains, was tested against the respiratory pathogens Pseudomonas aeruginosa and Staphylococcus aureus. Elafin killed both bacteria efficiently, with 93% killing of P. aeruginosa by 2.5 microM elafin and 48% killing of S. aureus by 25 microM elafin. For both organisms, full-length elafin was required to optimise bacterial killing. These findings represent the first demonstration of co-existent anti-proteolytic and anti-microbial functions for elafin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386612     DOI: 10.1016/s0014-5793(99)00670-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  56 in total

Review 1.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Staphylococcus colonization of the skin and antimicrobial peptides.

Authors:  Michael Otto
Journal:  Expert Rev Dermatol       Date:  2010-04

Review 3.  Antimicrobial peptides and the skin immune defense system.

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  J Allergy Clin Immunol       Date:  2008-04-25       Impact factor: 10.793

4.  Characterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells.

Authors:  Mette Eliasson; Anders I Olin; Johan A Malmström; Matthias Mörgelin; Mikael Bodelsson; Mattias Collin; Arne Egesten
Journal:  J Interferon Cytokine Res       Date:  2012-08-21       Impact factor: 2.607

Review 5.  Protecting the boundary: the sentinel role of host defense peptides in the skin.

Authors:  Jamie J Bernard; Richard L Gallo
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

6.  Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation.

Authors:  Diego Guerrieri; Nancy L Tateosian; Paulo C Maffía; Romina M Reiteri; Nicolás O Amiano; María J Costa; Ximena Villalonga; Mercedes L Sanchez; Silvia M Estein; Verónica E Garcia; Jean-Michel Sallenave; Héctor E Chuluyan
Journal:  Immunology       Date:  2011-05-17       Impact factor: 7.397

7.  Characterization of the ovine ortholog of secretory leukoprotease inhibitor.

Authors:  Thomas I Brown; Rohit Mistry; Robert Gray; Margaret Imrie; David D Collie; Jean-Michel Sallenave
Journal:  Mamm Genome       Date:  2005-09-14       Impact factor: 2.957

8.  Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells.

Authors:  Anna G Drannik; Kakon Nag; Xiao-Dan Yao; Bethany M Henrick; Sumiti Jain; T Blake Ball; Francis A Plummer; Charles Wachihi; Joshua Kimani; Kenneth L Rosenthal
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

9.  Dynamic and physical clustering of gene expression during epidermal barrier formation in differentiating keratinocytes.

Authors:  Jennifer M Taylor; Teresa L Street; Lizhong Hao; Richard Copley; Martin S Taylor; Patrick J Hayden; Gina Stolper; Richard Mott; Jotun Hein; Miriam F Moffatt; William O C M Cookson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

10.  Evolution of trappin genes in mammals.

Authors:  Akira Kato; Alejandro P Rooney; Yutaka Furutani; Shigehisa Hirose
Journal:  BMC Evol Biol       Date:  2010-01-29       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.